The role of microRNAs in intrahepatic cholangiocarcinoma

J Cell Mol Med. 2017 Jan;21(1):177-184. doi: 10.1111/jcmm.12951. Epub 2016 Sep 13.

Abstract

Intrahepatic cholangiocarcinoma (ICC) is the second most common primary hepatic malignancy with poor prognosis. Despite improvements in its diagnosis and therapy, the prognosis for ICC patients remains poor. An improved understanding of ICC pathogenesis and consequential identification of novel therapeutic targets would improve the prognosis of ICC patients. MicroRNAs (miRNAs) are a class of highly conserved, endogenous, small non-coding RNA molecules of 18-23 nucleotides in length, which regulate gene expression through complementary base-pairing with target messenger RNAs and subsequent gene silencing. Several studies have shown deregulated expression of miRNAs in ICC cell lines and tissues, in which these miRNAs play important roles in ICC apoptosis, cell proliferation, invasion, migration and metastasis. In this review, we illustrate the potential role of miRNA in the pathogenesis of ICC and explore the possibilities of using miRNAs as prognostic and diagnostic markers, as well as therapeutic targets in ICC.

Keywords: Intrahepatic cholangiocarcinoma; apoptosis; metastasis; microRNAs; prognosis; proliferation.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bile Duct Neoplasms / genetics*
  • Bile Duct Neoplasms / pathology
  • Cholangiocarcinoma / genetics*
  • Cholangiocarcinoma / pathology
  • Gene Expression / genetics
  • Humans
  • Liver Neoplasms / pathology
  • MicroRNAs / genetics*
  • Prognosis
  • RNA, Messenger / genetics

Substances

  • MicroRNAs
  • RNA, Messenger